Biopolymeric mucin and synthetic polymer analogs: Their structure, function and role in biomedical applications

Polymers

Volumn 8, Issue 3, 2016, Pages

  Authimoolam, Sundar P ^a   Dziubla, Thomas D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bioapplication; Biomimic; Drug delivery; Mucin; Polymer analog; Polymer networks; Tissue engineering

Indexed keywords

ASSOCIATION REACTIONS; BIOCHEMISTRY; DRUG DELIVERY; FUNCTIONAL POLYMERS; MEDICAL APPLICATIONS; MOLECULES; PHYSIOLOGY; POLYMERS; TISSUE; TISSUE ENGINEERING;

BIOAPPLICATIONS; BIOMEDICAL APPLICATIONS; BIOMIMIC; CHEMICAL VARIATIONS; FIBRILLAR AGGREGATES; FUNCTIONAL CHARACTERISTICS; MUCIN; POLYMER NETWORKS;

COMPLEX NETWORKS;

EID: 85010796628     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym8030071     Document Type: Review

References (218)

1. Rogers, D.F. Airway goblet cells: Responsive and adaptable front-line defenders. Eur. Respir. J. 1994, 7, 1690-1706.
2. Murray, P.A.; Levine, M.J.; Tabak, L.A.; Reddy, M.S. Specificity of salivary-bacterial interactions. 2. Evidence for a lectin on streptococcus sanguis with specificity for a NeuAc-α-2, 3Ga1-β-1, 3Ga1nac sequence. Biochem. Biophys. Res. Commun. 1982, 106, 390-396.
3. Kim, Y.; Dalhaimer, P.; Christian, D.A.; Discher, D.E. Polymeric worm micelles as nano-carriers for drug delivery. Nanotechnology 2005, 16, S484-S491.
4. Bradway, S.D.; Bergey, E.J.; Jones, P.C.; Levine, M.J. Oral mucosal pellicle. Adsorption and transpeptidation of salivary components to buccal epithelial cells. Biochem. J. 1989, 261, 887-896.
5. Kaditi, E.; Mountrichas, G.; Pispas, S.; Demetzos, C. Block copolymers for drug delivery nano systems (DDnSs). Curr. Med. Chem. 2012, 19, 5088-5100.
6. Praud, A.; Bootzeek, O.; Blache, Y. Synthesis of polymerizable vinyltriazoles: Development of an optimized one-pot strategy starting from 4-bromobutyne. Green Chem. 2013, 15, 1138-1141.
7. Bae, S.J.; Choi, H.; Choi, J.S. Synthesis of polymerizable amphiphiles with basic oligopeptides for gene delivery application. Polymer Korea 2013, 37, 94-99.
8. Prakobphol, A.; Levine, M.J.; Tabak, L.A.; Reddy, M.S. Purification of a low-molecular-weight, mucin-type glycoprotein from human submandibular-sublingual saliva. Carbohydr. Res. 1982, 108, 111-122.
9. Tabak, L.A. In defense of the oral cavity: The protective role of the salivary secretions. Pediatr. Dent. 2006, 28, 110-117.
10. Hill, H.D., Jr.; Reynolds, J.A.; Hill, R.L. Purification, composition, molecular weight, and subunit structure of ovine submaxillary mucin. J. Biol. Chem. 1977, 252, 3791-3798.
11. Thornton, D.J.; Rousseau, K.; McGuckin, M.A. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 2008, 70, 459-486.
12. Sigurdsson, H.H.; Kirch, J.; Lehr, C.M. Mucus as a barrier to lipophilic drugs. Int. J. Pharm. 2013, 453, 56-64.
13. Edsman, K.; Hagerstrom, H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J. Pharm. Pharmacol. 2005, 57, 3-22.
14. Bradway, S.D.; Bergey, E.J.; Scannapieco, F.A.; Ramasubbu, N.; Zawacki, S.; Levine, M.J. Formation of salivary-mucosal pellicle: The role of transglutaminase. Biochem. J. 1992, 284 Pt 2, 557-564.
15. Authimoolam, S.P.; Vasilakes, A.L.; Shah, N.M.; Puleo, D.A.; Dziubla, T.D. Synthetic oral mucin mimic from polymer micelle networks. Biomacromolecules 2014, 15, 3099-3111.
16. Gibbins, H.L.; Yakubov, G.E.; Proctor, G.B.; Wilson, S.; Carpenter, G.H. What interactions drive the salivary mucosal pellicle formation? Colloid Surf. B 2014, 120, 184-192.
17. Houver, G.J.; Frank, R.M. Ultrastructural study of human dental plaque. Inf. Dent. 1971, 53, 4191-4200.
18. Lie, T. Scanning and transmission electron microscope study of pellicle morphogenesis. Scand. J. Dent. Res. 1977, 85, 217-231.
19. Lendenmann, U.; Grogan, J.; Oppenheim, F.G. Saliva and dental pellicle-A review. Adv. Dent. Res. 2000, 14, 22-28.
20. Hong, Z.N.; Chasan, B.; Bansil, R.; Turner, B.S.; Bhaskar, K.R.; Afdhal, N.H. Atomic force microscopy reveals aggregation of gastric mucin at low ph. Biomacromolecules 2005, 6, 3458-3466.
21. Baek, J.H.; Krasieva, T.; Tang, S.; Ahn, Y.; Kim, C.S.; Vu, D.; Chen, Z.;Wilder-Smith, P. Optical approach to the salivary pellicle. J. Biomed. Opt. 2009, 14.
22. Johansson, M.E.; Larsson, J.M.; Hansson, G.C. The two mucus layers of colon are organized by the muc2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 2011, 108, 4659-4665.
23. Cone, R.A. Barrier properties of mucus. Adv. Drug Deliver. Rev. 2009, 61, 75-85.
24. Khanvilkar, K.; Donovan, M.D.; Flanagan, D.R. Drug transfer through mucus. Adv. Drug Deliv. Rev. 2001, 48, 173-193.
25. Atuma, C.; Strugala, V.; Allen, A.; Holm, L. The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280, G922-G929.
26. Johansson, M.E.V.; Phillipson, M.; Petersson, J.; Velcich, A.; Holm, L.; Hansson, G.C. The inner of the two muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 2008, 105, 15064-15069.
27. Gustafsson, J.K.; Ermund, A.; Johansson, M.E.V.; Schutte, A.; Hansson, G.C.; Sjovall, H. An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G430-G438.
28. Morgenroth, K.; Bolz, J. Morphological features of the interaction between mucus and surfactant on the bronchial-mucosa. Respiration 1985, 47, 225-231.
29. Ha, E.V.; Rogers, D.F. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016, 97, 84-100.
30. Cao, X.; Bansil, R.; Bhaskar, K.R.; Turner, B.S.; LaMont, J.T.; Niu, N.; Afdhal, N.H. pH-dependent conformational change of gastric mucin leads to sol-gel transition. Biophys. J. 1999, 76, 1250-1258.
31. Brunelli, R.; Papi, M.; Arcovito, G.; Bompiani, A.; Castagnola, M.; Parasassi, T.; Sampaolese, B.; Vincenzoni, F.; de Spirito, M. Globular structure of human ovulatory cervical mucus. FASEB J. 2007, 21, 3872-3876.
32. Menarguez, M.; Pastor, L.M.; Odeblad, E. Morphological characterization of different human cervical mucus types using light and scanning electron microscopy. Hum. Reprod. 2003, 18, 1782-1789.
33. Kirkham, S.; Sheehan, J.K.; Knight, D.; Richardson, P.S.; Thornton, D.J. Heterogeneity of airways mucus: Variations in the amounts and glycoforms of the major oligomeric mucins muc5ac and muc5b. Biochem. J. 2002, 361, 537-546.
34. Lai, S.K.; Wang, Y.Y.; Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 2009, 61, 158-171.
35. Round, A.N.; Berry, M.; McMaster, T.J.; Stoll, S.; Gowers, D.; Corfield, A.P.; Miles, M.J. Heterogeneity and persistence length in human ocular mucins. Biophys. J. 2002, 83, 1661-1670.
36. Bansil, R.; Turner, B.S. Mucin structure, aggregation, physiological functions and biomedical applications. Curr. Opin. Colloid Interface Sci. 2006, 11, 164-170.
37. Allen, A.; Leonard, A.J.; Sellers, L.A. The mucus barrier. Its role in gastroduodenal mucosal protection. J. Clin. Gastroenterol. 1988, 10, S93-S98.
38. Ermund, A.; Schutte, A.; Johansson, M.E.; Gustafsson, J.K.; Hansson, G.C. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the peyer's patches. Am. J. Physiol. Gastrointest. Liver. Physiol. 2013, 305, G341-G347.
39. Collins, L.M.; Dawes, C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 1987, 66, 1300-1302.
40. Olmsted, S.S.; Padgett, J.L.; Yudin, A.I.; Whaley, K.J.; Moench, T.R.; Cone, R.A. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 2001, 81, 1930-1937.
41. Allen, A.; Flemstrom, G.; Garner, A.; Kivilaakso, E. Gastroduodenal mucosal protection. Physiol. Rev. 1993, 73, 823-857.
42. Kirch, J.; Schneider, A.; Abou, B.; Hopf, A.; Schaefer, U.F.; Schneider, M.; Schall, C.;Wagner, C.; Lehr, C.M. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus. Proc. Natl. Acad. Sci. USA 2012, 109, 18355-18360.
43. Tinanoff, N.; Glick, P.L.; Weber, D.F. Ultrastructure of organic films on the enamel surface. Caries Res. 1976, 10, 19-32.
44. De Vrese, M.; Marteau, P.R. Probiotics and prebiotics: Effects on diarrhea. J. Nutr. 2007, 137, 803S-811S.
45. Matsui, H.; Wagner, V.E.; Hill, D.B.; Schwab, U.E.; Rogers, T.D.; Button, B.; Taylor, R.M.; Superfine, R.; Rubinstein, M.; Iglewski, B.H.; et al. A physical linkage between cystic fibrosis airway surface dehydration and pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. USA 2006, 103, 18131-18136.
46. Oliver, D. Microbes and you: Normal flora. Available online: http://www.scq.ubc.ca/microbes-andyou-normal-flora/(accessed on 20 August 2006).
47. Chao, C.C.; Stuebben, A.M.; Butala, S.M. Characterization of ocular mucus extracts by crossed immunoelectrophoretic techniques. Investig. Ophthalmol. Vis. Sci. 1990, 31, 1127-1135.
48. Holly, F.J.; Lemp, M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 1977, 22, 69-87.
49. Mantelli, F.; Argueso, P. Functions of ocular surface mucins in health and disease. Curr. Opin. Allergy Clin. Immunol. 2008, 8, 477-483.
50. Tan, J.; Keay, L.; Jalbert, I.; Naduvilath, T.J.; Sweeney, D.F.; Holden, B.A. Mucin balls with wear of conventional and silicone hydrogel contact lenses. Optom. Vis. Sci. 2003, 80, 291-297.
51. Szczotka-Flynn, L.; Benetz, B.A.; Lass, J.; Albright, M.; Gillespie, B.; Kuo, J.; Fonn, D.; Sethi, A.; Rimm, A. The association between mucin balls and corneal infiltrative events during extended contact lens wear. Cornea 2011, 30, 535-542.
52. Hopcraft, M.S.; Tan, C. Xerostomia: An update for clinicians. Aust. Dent. J. 2010, 55, 238-244.
53. Sasportas, L.S.; Hosford, D.N.; Sodini, M.A.; Waters, D.J.; Zambricki, E.A.; Barral, J.K.; Graves, E.E.; Brinton, T.J.; Yock, P.G.; le, Q.T.; et al. Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013, 116, E37-E51.
54. Turner, M.D.; Ship, J.A. Dry mouth and its effects on the oral health of elderly people. J. Am. Dent. Assoc. 2007, 138, 15s-20s.
55. Mese, H.; Matsuo, R. Salivary secretion, taste and hyposalivation. J. Oral Rehabil. 2007, 34, 711-723.
56. Xu, T.; Levitz, S.M.; Diamond, R.D.; Oppenheim, F.G. Anticandidal activity of major human salivary histatins. Infect. Immun. 1991, 59, 2549-2554.
57. Kavanagh, K.; Dowd, S. Histatins: Antimicrobial peptides with therapeutic potential. J. Pharm. Pharmacol. 2004, 56, 285-289.
58. Torres, S.R.; Garzino-Demo, A.; Meiller, T.F.; Meeks, V.; Jabra-Rizk, M.A. Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses 2009, 52, 11-15.
59. Muralidharan, R.; Bobek, L.A. Antifungal activity of human salivary mucin-derived peptide, muc7 12-mer, in a murine model of oral candidiasis. J. Pept. Res. 2005, 66, 82-89.
60. Lin, A.L.; Johnson, D.A.; Patterson, T.F.; Wu, Y.; Lu, D.L.; Shi, Q.; Yeh, C.K. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol. Immunol. 2001, 16, 270-278.
61. Jainkittivong, A.; Lin, A.L.; Johnson, D.A.; Langlais, R.P.; Yeh, C.K. Salivary secretion, mucin concentrations and candida carriage in HIV-infected patients. Oral Dis. 2009, 15, 229-234.
62. Khan, S.A.; Fidel, P.L., Jr.; Thunayyan, A.A.; Varlotta, S.; Meiller, T.F.; Jabra-Rizk, M.A. Impaired histatin-5 levels and salivary antimicrobial activity against in hiv infected individuals. J. AIDS Clin. Res. 2013, 4.
63. Kim, W.D. Lung mucus: A clinician's view. Eur. Respir. J. 1997, 10, 1914-1917.
64. Clamp, J.R.; Ene, D. The gastric-mucosal barrier. Method Find Exp. Clin. 1989, 11, 19-25.
65. Allen, A.; Flemstrom, G. Gastroduodenal mucus bicarbonate barrier: Protection against acid and pepsin. Am. J. Physiol. Cell Physiol. 2005, 288, C1-C19.
66. Crampton, J.R. Gastroduodenal mucus and bicarbonate-The defensive zone. Q. J. Med. 1988, 67, 269-272.
67. Juntunen, M.; Kirjavainen, P.V.; Ouwehand, A.C.; Salminen, S.J.; Isolauri, E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 2001, 8, 293-296.
68. Chen, S.J.; Liu, X.W.; Liu, J.P.; Yang, X.Y.; Lu, F.G. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J. Gastroenterol. 2014, 20, 9468-9475.
69. Vaughan, E.E.; Mollet, B. Probiotics in the new millennium. Die Nahr. 1999, 43, 148-153.
70. Cremonini, F.; di Caro, S.; Nista, E.C.; Bartolozzi, F.; Capelli, G.; Gasbarrini, G.; Gasbarrini, A. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2002, 16, 1461-1467.
71. Verna, E.C.; Lucak, S. Use of probiotics in gastrointestinal disorders: What to recommend? Ther. Adv. Gastroenterol. 2010, 3, 307-319.
72. Allen, S.J.; Martinez, E.G.; Gregorio, G.V.; Dans, L.F. Probiotics for treating acute infectious diarrhoea. Sao Paulo Med. J. 2011, 129, 185.
73. Ohland, C.L.; Macnaughton, W.K. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G807-G819.
74. Lai, S.K.; Wang, Y.Y.; Hida, K.; Cone, R.; Hanes, J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc. Natl. Acad. Sci. USA 2010, 107, 598-603.
75. Lieleg, O.; Lieleg, C.; Bloom, J.; Buck, C.B.; Ribbeck, K. Mucin biopolymers as broad-spectrum antiviral agents. Biomacromolecules 2012, 13, 1724-1732.
76. Elstein, M. Cervical mucus: Its physiological role and clinical significance. Adv. Exp. Med. Biol. 1982, 144, 301-318.
77. Becher, N.; AdamsWaldorf, K.; Hein, M.; Uldbjerg, N. The cervical mucus plug: Structured review of the literature. Acta Obstet. Gynecol. Scand. 2009, 88, 502-513.
78. Shukair, S.A.; Allen, S.A.; Cianci, G.C.; Stieh, D.J.; Anderson, M.R.; Baig, S.M.; Gioia, C.J.; Spongberg, E.J.; Kauffman, S.M.; McRaven, M.D.; et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol. 2013, 6, 427-434.
79. Boukari, H.; Brichacek, B.; Stratton, P.; Mahoney, S.F.; Lifson, J.D.; Margolis, L.; Nossal, R. Movements of HIV-virions in human cervical mucus. Biomacromolecules 2009, 10, 2482-2488.
80. Chretien, F.C. Ultrastructure and variations of human cervical mucus during pregnancy and the menopause. Acta Obstet. Gynecol. Scand. 1978, 57, 337-348.
81. Moore, W.E.; Moore, L.V. The bacteria of periodontal diseases. Periodontology 2000 1994, 5, 66-77.
82. Paster, B.J.; Boches, S.K.; Galvin, J.L.; Ericson, R.E.; Lau, C.N.; Levanos, V.A.; Sahasrabudhe, A.; Dewhirst, F.E. Bacterial diversity in human subgingival plaque. J. Bacteriol. 2001, 183, 3770-3783.
83. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 2005, 43, 5721-5732.
84. Authimoolam, S.P.; Lakes, A.L.; Puleo, D.A.; Dziubla, T.D. Layer-by-layers of polymeric micelles as a biomimetic drug-releasing network. Macromol. Biosci. 2015.
85. Nieuw Amerongen, A.V.; Oderkerk, C.H.; Driessen, A.A. Role of mucins from human whole saliva in the protection of tooth enamel against demineralization in vitro. Caries Res. 1987, 21, 297-309.
86. Bonilha, H.S.; White, L.; Kuckhahn, K.; Gerlach, T.T.; Deliyski, D.D. Vocal fold mucus aggregation in persons with voice disorders. J. Commun. Disord. 2012, 45, 304-311.
87. Ramos, F.L.; Krahnke, J.S.; Kim, V. Clinical issues of mucus accumulation in copd. Int. J. Chronic Obstr. Pulm. Dis. 2014, 9, 139-150.
88. Izuhara, K.; Ohta, S.; Shiraishi, H.; Suzuki, S.; Taniguchi, K.; Toda, S.; Tanabe, T.; Yasuo, M.; Kubo, K.; Hoshino, T.; et al. The mechanism of mucus production in bronchial asthma. Curr. Med. Chem. 2009, 16, 2867-2875.
89. Matsui, H.; Verghese, M.W.; Kesimer, M.; Schwab, U.E.; Randell, S.H.; Sheehan, J.K.; Grubb, B.R.; Boucher, R.C. Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J. Immunol. 2005, 175, 1090-1099.
90. Nesbitt, W.E.; Doyle, R.J.; Taylor, K.G. Hydrophobic interactions and the adherence of streptococcus sanguis to hydroxylapatite. Infect. Immun. 1982, 38, 637-644.
91. Tabak, L.A.; Levine, M.J.; Mandel, I.D.; Ellison, S.A. Role of salivary mucins in the protection of the oral cavity. J. Oral Pathol. 1982, 11, 1-17.
92. McBride, B.C.; Gisslow, M.T. Role of sialic acid in saliva-induced aggregation of streptococcus sanguis. Infect. Immun. 1977, 18, 35-40.
93. Gibbons, R.J. Bacterial adhesion to oral tissues: A model for infectious diseases. J. Dent. Res. 1989, 68, 750-760.
94. Loomis, R.E.; Prakobphol, A.; Levine, M.J.; Reddy, M.S.; Jones, P.C. Biochemical and biophysical comparison of two mucins from human submandibular-sublingual saliva. Arch. Biochem. Biophys. 1987, 258, 452-464.
95. Levine, M.J.; Reddy, M.S.; Tabak, L.A.; Loomis, R.E.; Bergey, E.J.; Jones, P.C.; Cohen, R.E.; Stinson, M.W.; Al-Hashimi, I. Structural aspects of salivary glycoproteins. J. Dent. Res. 1987, 66, 436-441.
96. Jachak, A.; Lai, S.K.; Hida, K.; Suk, J.S.; Markovic, N.; Biswal, S.; Breysse, P.N.; Hanes, J. Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology 2012, 6, 614-622.
97. Coaker, H. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Nanomedicine UK 2014, 9, 382-383.
98. Crater, J.S.; Carrier, R.L. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol. Biosci. 2010, 10, 1473-1483.
99. Li, L.D.; Crouzier, T.; Sarkar, A.; Dunphy, L.; Han, J.; Ribbeck, K. Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier. Biophys. J. 2013, 105, 1357-1365.
100. Wang, Y.Y.; Lai, S.K.; Suk, J.S.; Pace, A.; Cone, R.; Hanes, J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew. Chem. Int. Ed. Engl. 2008, 47, 9726-9729.
101. Saltzman, W.M.; Radomsky, M.L.; Whaley, K.J.; Cone, R.A. Antibody diffusion in human cervical-mucus. Biophys. J. 1994, 66, 508-515.
102. Chen, A.; McKinley, S.A.; Wang, S.; Shi, F.; Mucha, P.J.; Forest, M.G.; Lai, S.K. Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion. Biophys. J. 2014, 106, 2028-2036.
103. Wang, Y.Y.; Kannan, A.; Nunn, K.L.; Murphy, M.A.; Subramani, D.B.; Moench, T.; Cone, R.; Lai, S.K. IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections. Mucosal Immunol. 2014, 7, 1036-1044.
104. Fahrbach, K.M.; Malykhina, O.; Stieh, D.J.; Hope, T.J. Differential binding of IgG and IgA to mucus of the female reproductive tract. PLoS ONE 2013, 8, e76176.
105. Cu, Y.; Saltzman, W.M. Drug delivery: Stealth particles give mucus the slip. Nat. Mater. 2009, 8, 11-13.
106. Lieleg, O.; Ribbeck, K. Biological hydrogels as selective diffusion barriers. Trends Cell Biol. 2011, 21, 543-551.
107. Ensign, L.M.; Tang, B.C.; Wang, Y.Y.; Tse, T.A.; Hoen, T.; Cone, R.; Hanes, J. Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci. Transl. Med. 2012, 4.
108. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 2001, 52, 117-126.
109. Karavas, E.; Georgarakis, E.; Bikiaris, D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 2006, 64, 115-126.
110. Ramineni, S.K.; Cunningham, L.L., Jr.; Dziubla, T.D.; Puleo, D.A. Competing properties of mucoadhesive films designed for localized delivery of imiquimod. Biomater. Sci. 2013, 1, 753-762.
111. Ponchel, G.; Montisci, M.J.; Dembri, A.; Durrer, C.; Duchene, D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharm. Biopharm. 1997, 44, 25-31.
112. Larhed, A.W.; Artursson, P.; Grasjo, J.; Bjork, E. Diffusion of drugs in native and purified gastrointestinal mucus. J. Pharm. Sci. 1997, 86, 660-665.
113. Larhed, A.W.; Artursson, P.; Bjork, E. The influence of intestinal mucus components on the diffusion of drugs. Pharm. Res 1998, 15, 66-71.
114. Patil, S.B.; Sawant, K.K. Mucoadhesive microspheres: A promising tool in drug delivery. Curr. Drug Deliv. 2008, 5, 312-318.
115. Araujo, F.; Shrestha, N.; Shahbazi, M.A.; Fonte, P.; Makila, E.M.; Salonen, J.J.; Hirvonen, J.T.; Granja, P.L.; Santos, H.A.; Sarmento, B. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium. Biomaterials 2014, 35, 9199-9207.
116. Ludwig, A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev. 2005, 57, 1595-1639.
117. Zhou, W.; Wang, Y.; Jian, J.; Song, S. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B. Int. J. Nanomed. 2013, 8, 3715-3728.
118. Khutoryanskaya, O.V.; Morrison, P.W.; Seilkhanov, S.K.; Mussin, M.N.; Ozhmukhametova, E.K.; Rakhypbekov, T.K.; Khutoryanskiy, V.V. Hydrogen-bonded complexes and blends of poly(acrylic acid) and methylcellulose: Nanoparticles and mucoadhesive films for ocular delivery of riboflavin. Macromol. Biosci. 2014, 14, 225-234.
119. Ceulemans, J.; Vermeire, A.; Adriaens, E.; Remon, J.P.; Ludwig, A. Evaluation of a mucoadhesive tablet for ocular use. J. Control. Release 2001, 77, 333-344.
120. Salamat-Miller, N.; Chittchang, M.; Johnston, T.P. The use of mucoadhesive polymers in buccal drug delivery. Adv. Drug Deliv. Rev. 2005, 57, 1666-1691.
121. Laffleur, F. Mucoadhesive polymers for buccal drug delivery. Drug Dev. Ind. Pharm. 2014, 40, 591-598.
122. Xu, J.K.; Strandman, S.; Zhu, J.X.X.; Barralet, J.; Cerruti, M. Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery. Biomaterials 2015, 37, 395-404.
123. Gavin, A.; Pham, J.T.H.; Wang, D.W.; Brownlow, B.; Elbayoumi, T.A. Layered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeutics. Int. J. Nanomed. 2015, 10, 1569-1584.
124. Sharma, N.; Kulkarni, G.T.; Sharma, A.; Bhatnagar, A.; Kumar, N. Natural mucoadhesive microspheres of Abelmoschus esculentus polysaccharide as a new carrier for nasal drug delivery. J. Microencapsul. 2013, 30, 589-598.
125. Jiang, L.; Gao, L.;Wang, X.; Tang, L.; Ma, J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev. Ind. Pharm. 2010, 36, 323-336.
126. Hansen, K.; Kim, G.; Desai, K.G.; Patel, H.; Olsen, K.F.; Curtis-Fisk, J.; Tocce, E.; Jordan, S.; Schwendeman, S.P. Feasibility investigation of cellulose polymers formucoadhesive nasal drug delivery applications. Mol. Pharm. 2015, 12, 2732-2741.
127. Devkar, T.B.; Tekade, A.R.; Khandelwal, K.R. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using delonix regia gum as a natural mucoadhesive polymer. Colloids Surf. B Biointerfaces 2014, 122, 143-150.
128. Alpar, H.O.; Somavarapu, S.; Atuah, K.N.; Bramwell, V.W. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev. 2005, 57, 411-430.
129. Alipour, S.; Montaseri, H.; Tafaghodi, M. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids Surf. B Biointerfaces 2010, 81, 521-529.
130. Sakagami, M.; Sakon, K.; Kinoshita, W.; Makino, Y. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J. Control. Release 2001, 77, 117-129.
131. Liu, X.B.; Ye, J.X.; Quan, L.H.; Liu, C.Y.; Deng, X.L.; Yang, M.; Liao, Y.H. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur. J. Pharm. Biopharm. 2008, 70, 845-852.
132. De Araujo Pereira, R.R.; Bruschi, M.L. Vaginal mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 2012, 38, 643-652.
133. Valenta, C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev. 2005, 57, 1692-1712.
134. Acarturk, F. Mucoadhesive vaginal drug delivery systems. Recent Pat. Drug Deliv. Formul. 2009, 3, 193-205.
135. Caramella, C.M.; Rossi, S.; Ferrari, F.; Bonferoni, M.C.; Sandri, G. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv. Drug Deliv. Rev. 2015, 92, 39-52.
136. Furst, T.; Piette, M.; Lechanteur, A.; Evrard, B.; Piel, G. Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. Eur. J. Pharm. Biopharm. 2015, 95, 128-135.
137. Yuan, Y.; Cui, Y.; Zhang, L.; Zhu, H.P.; Guo, Y.S.; Zhong, B.; Hu, X.; Zhang, L.; Wang, X.H.; Chen, L. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int. J. Pharm. 2012, 430, 114-119.
138. Fawaz, F.; Koffi, A.; Guyot, M.; Millet, P. Comparative in vitro-in vivo study of two quinine rectal gel formulations. Int. J. Pharm. 2004, 280, 151-162.
139. El-Leithy, E.S.; Shaker, D.S.; Ghorab, M.K.; Abdel-Rashid, R.S. Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration. AAPS PharmSciTech 2010, 11, 1695-1702.
140. Ofokansi, K.C.; Adikwu, M.U.; Okore, V.C. Preparation and evaluation of mucin-gelatin mucoadhesive microspheres for rectal delivery of ceftriaxone sodium. Drug Dev. Ind. Pharm. 2007, 33, 691-700.
141. Maurya, S.K.; Pathak, K.; Bali, V. Therapeutic potential of mucoadhesive drug delivery systems-An updated patent review. Recent Pat. Drug Deliv. Formul. 2010, 4, 256-265.
142. Thasneem, Y.M.; Rekha, M.R.; Sajeesh, S.; Sharma, C.P. Biomimetic mucin modified plga nanoparticles for enhanced blood compatibility. J. Colloid Interface Sci. 2013, 409, 237-244.
143. Janairo, R.R.R.; Zhu, Y.Q.; Chen, T.; Li, S. Mucin covalently bonded to microfibers improves the patency of vascular grafts. Tissue Eng. A 2014, 20, 285-293.
144. Sandberg, T.; Karlsson Ott, M.; Carlsson, J.; Feiler, A.; Caldwell, K.D. Potential use of mucins as biomaterial coatings. Ii. Mucin coatings affect the conformation and neutrophil-activating properties of adsorbed host proteins-Toward a mucosal mimic. J. Biomed. Mater. Res. A 2009, 91, 773-785.
145. Shi, L.; Ardehali, R.; Caldwell, K.D.; Valint, P. Mucin coating on polymeric material surfaces to suppress bacterial adhesion. Colloid Surf. B 2000, 17, 229-239.
146. Crouzier, T.; Jang, H.; Ahn, J.; Stocker, R.; Ribbeck, K. Cell patterning with mucin biopolymers. Biomacromolecules 2013, 14, 3010-3016.
147. Johnson, K.; Fath, K.; Henricus, M.; Banerjee, I. Self-assembly and growth of smart cell-adhesive mucin-bound microtubes. Soft Matter 2009, 7, 21-36.
148. Chen, X.; Lee, G.S.; Zettl, A.; Bertozzi, C.R. Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew. Chem. Int. Ed. Engl. 2004, 43, 6111-6116.
149. Drug, E.; Landesman-Milo, D.; Belgorodsky, B.; Ermakov, N.; Frenkel-Pinter, M.; Fadeev, L.; Peer, D.; Gozin, M. Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes. Chem. Res. Toxicol. 2011, 24, 314-320.
150. Belgorodsky, B.; Drug, E.; Fadeev, L.; Hendler, N.; Mentovich, E.; Gozin, M. Mucin complexes of nanomaterials: First biochemical encounter. Small 2010, 6, 262-269.
151. Lasky, L.A.; Singer, M.S.; Dowbenko, D.; Imai, Y.; Henzel, W.J.; Grimley, C.; Fennie, C.; Gillett, N.;Watson, S.R.; Rosen, S.D. An endothelial ligand for l-selectin is a novel mucin-like molecule. Cell 1992, 69, 927-938.
152. Wahrenbrock, M.; Borsig, L.; le, D.; Varki, N.; Varki, A. Selectin-mucin interactions as a probable molecular explanation for the association of trousseau syndrome with mucinous adenocarcinomas. J. Clin. Investig. 2003, 112, 853-862.
153. Aigner, S.; Sthoeger, Z.M.; Fogel, M.; Weber, E.; Zarn, J.; Ruppert, M.; Zeller, Y.; Vestweber, D.; Stahel, R.; Sammar, M.; et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 1997, 89, 3385-3395.
154. Chen, S.H.; Dallas, M.R.; Balzer, E.M.; Konstantopoulos, K. Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J. 2012, 26, 1349-1359.
155. Carson, D.D.; Julian, J.; Lessey, B.A.; Prakobphol, A.; Fisher, S.J. Muc1 is a scaffold for selectin ligands in the human uterus. Front. Biosci. 2006, 11, 2903-2908.
156. Crouzier, T.; Beckwitt, C.H.; Ribbeck, K. Mucin multilayers assembled through sugar-lectin interactions. Biomacromolecules 2012, 13, 3401-3408.
157. Polak, R.; Crouzier, T.; Lim, R.M.; Ribbeck, K.; Beppu, M.M.; Pitombo, R.N.M.; Cohen, R.E.; Rubner, M.F. Sugar-mediated disassembly of mucin/lectin multi layers and their use as pH-tolerant, on-demand sacrificial layers. Biomacromolecules 2014, 15, 3093-3098.
158. Perez-Vilar, J.; Hill, R.L. The structure and assembly of secreted mucins. J. Biol. Chem. 1999, 274, 31751-31754.
159. Jain, S.K.; Jangdey, M.S. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of helicobacter pylori. Mol. Pharm. 2009, 6, 295-304.
160. Adebisi, A.O.; Conway, B.R. Lectin-conjugated microspheres for eradication of helicobacter pylori infection and interaction with mucus. Int. J. Pharm. 2014, 470, 28-40.
161. Wang, B.; Liu, Z.Y.; Xu, Y.L.; Li, Y.H.; An, T.Z.; Su, Z.H.; Peng, B.; Lin, Y.; Wang, Q. Construction of glycoprotein multilayers using the layer-by-layer assembly technique. J. Mater. Chem. 2012, 22, 17954-17960.
162. Svensson, O.; Lindh, L.; Cardenas, M.; Arnebrant, T. Layer-by-layer assembly of mucin and chitosan-Influence of surface properties, concentration and type of mucin. J. Colloid Interface Sci. 2006, 299, 608-616.
163. Ivanov, A.E.; Solodukhina, N.M.; Nilsson, L.; Nikitin, M.P.; Nikitin, P.I.; Zubov, V.P.; Vikhrov, A.A. Binding of mucin to water-soluble and surface-grafted boronate-containing polymers. Polym. Sci. Ser. A 2012, 54, 1-10.
164. Ding, Z.B.; Guan, Y.; Zhang, Y.; Zhu, X.X. Layer-by-layer multilayer films linked with reversible boronate ester bonds with glucose-sensitivity under physiological conditions. Soft Matter 2009, 5, 2302-2309.
165. Vissink, A.; Schaub, R.M.; van Rijn, L.J.; Gravenmade, E.J.; Panders, A.K.; Vermey, A. The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia. Gerodontology 1987, 6, 95-101.
166. Blixt-Johansen, G.; Ek, A.C.; Ganowiak, W.; Granerus, A.K.; von Schenck, H.;Unosson, M.;Wiesel, K. Improvement of oral mucosa with mucin containing artificial saliva in geriatric patients. Arch. Gerontol. Geriatr. 1992, 14, 193-201.
167. S-Gravenmade, E.J.; Roukema, P.A.; Panders, A.K. The effect of mucin-containing artificial saliva on severe xerostomia. Int. J. Oral Surg. 1974, 3, 435-439.
168. Duxbury, A.J.; Thakker, N.S.;Wastell, D.G. A double-blind cross-over trial of a mucin-containing artificial saliva. Br. Dent. J. 1989, 166, 115-120.
169. Vissink, A.; Sgravenmade, E.J.; Panders, A.K.; Vermey, A.; Petersen, J.K.; Visch, L.L.; Schaub, R.M.H. A clinical comparison between commercially available mucin-containing and cmc-containing saliva substitutes. Int. J. Oral Surg. 1983, 12, 232-238.
170. Vissink, A.; Waterman, H.A.; Sgravenmade, E.J.; Panders, A.K.; Vermey, A. Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide. J. Oral Pathol. Med. 1984, 13, 22-28.
171. Davies, A.N.; Daniels, C.; Pugh, R.; Sharma, K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat. Med. 1998, 12, 105-111.
172. Sweeney, M.P.; Bagg, J.; Baxter, W.P.; Aitchison, T.C. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat. Med. 1997, 11, 225-232.
173. Duffy, C.V.; David, L.; Crouzier, T. Covalently-crosslinked mucin biopolymer hydrogels for sustained drug delivery. Acta Biomater. 2015, 20, 51-59.
174. Ensign, L.M.; Cone, R.; Hanes, J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 2012, 64, 557-570.
175. Urtti, A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 2006, 58, 1131-1135.
176. Gniewek, P.; Kolinski, A. Coarse-grained modeling of mucus barrier properties. Biophys. J. 2012, 102, 195-200.
177. Perez-Vilar, J.; Mabolo, R. Gel-forming mucins. Notions from in vitro studies. Histol. Histopathol. 2007, 22, 455-464.
178. Lai, S.K.; O'Hanlon, D.E.; Harrold, S.; Man, S.T.; Wang, Y.Y.; Cone, R.; Hanes, J. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. USA 2007, 104, 1482-1487.
179. Norris, D.A.; Sinko, P.J. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J. Appl. Polym. Sci. 1997, 63, 1481-1492.
180. Sakuma, S.; Sudo, R.; Suzuki, N.; Kikuchi, H.; Akashi, M.; Hayashi, M. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int. J. Pharm. 1999, 177, 161-172.
181. Dalsin, J.L.; Hu, B.H.; Lee, B.P.; Messersmith, P.B. Mussel adhesive protein mimetic polymers for the preparation of nonfouling surfaces. J. Am. Chem. Soc. 2003, 125, 4253-4258.
182. Kojima, C.; Fukada, H.; Inui, T. Synthesis and binding properties of peptidomimetics based on a dendritic polymer. Polym. J. 2013, 45, 339-345.
183. Tang, Z.Y.;Wang, Y.; Podsiadlo, P.; Kotov, N.A. Biomedical applications of layer-by-layer assembly: From biomimetics to tissue engineering. Adv. Mater. 2007, 19, 906.
184. Sill, T.J.; von Recum, H.A. Electro spinning: Applications in drug delivery and tissue engineering. Biomaterials 2008, 29, 1989-2006.
185. Geckil, H.; Xu, F.; Zhang, X.H.; Moon, S.; Demirci, U. Engineering hydrogels as extracellular matrix mimics. Nanomedicine UK 2010, 5, 469-484.
186. Lee, M.; Cho, B.K.; Zin, W.C. Supramolecular structures from rod-coil block copolymers. Chem. Rev. 2001, 101, 3869-3892.
187. Lee, J.H.; Choi, Y.J.; Lim, Y.B. Self-assembled filamentous nanostructures for drug/gene delivery applications. Expert Opin. Drug Deliv. 2010, 7, 341-351.
188. Discher, D.E.; Eisenberg, A. Polymer vesicles. Science 2002, 297, 967-973.
189. Geng, Y.; Dalhaimer, P.; Discher, D. Synthetic filamentous phages from self-assembling biocompatible diblock copolymers. Abstr. Pap. Am. Chem. Soc. 2005, 229, U970.
190. Kim, T.H.; Mount, C.W.; Dulken, B.W.; Ramos, J.; Fu, C.J.; Khant, H.A.; Chiu, W.; Gombotz, W.R.; Pun, S.H. Filamentous, mixed micelles of triblock copolymers enhance tumor localization of indocyanine green in a murine xenograft model. Mol. Pharm. 2012, 9, 135-143.
191. Dalhaimer, P.; Engler, A.J.; Parthasarathy, R.; Discher, D.E. Targeted worm micelles. Biomacromolecules 2004, 5, 1714-1719.
192. Dalhaimer, P.; Discher, D.E. Targeted worm micelles for drug delivery. Abstr. Pap. Am. Chem. Soc. 2004, 228, U495.
193. Discher, D.E.; Dalhaimer, P.; Engler, A.J.; Parthasarthy, R. Targeted worm-like micelles. Abstr. Pap. Am. Chem. Soc. 2005, 230, U4026-U4027.
194. Geng, Y.; Dalhaimer, P.; Cai, S.S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2, 249-255.
195. Shuvaev, V.V.; Ilies, M.A.; Simone, E.; Zaitsev, S.; Kim, Y.; Cai, S.; Mahmud, A.; Dziubla, T.; Muro, S.; Discher, D.E.; et al. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano 2011, 5, 6991-6999.
196. Pal, J.; Sanwaria, S.; Srivastava, R.; Nandan, B.; Horechyy, A.; Stamm, M.; Chen, H.L. Hairy polymer nanofibers via self-assembly of block copolymers. J. Mater. Chem. 2012, 22, 25102-25107.
197. Mahalingam, A.; Jay, J.I.; Langheinrich, K.; Shukair, S.; McRaven, M.D.; Rohan, L.C.; Herold, B.C.; Hope, T.J.; Kiser, P.F. Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials 2011, 32, 8343-8355.
198. Xu, J.; Yang, D.G.; Li, W.J.; Gao, Y.; Chen, H.B.; Li, H.M. Phenylboronate-diol crosslinked polymer gels with reversible sol-gel transition. Polymer 2011, 52, 4268-4276.
199. Guo, Q.Q.; Wu, Z.M.; Zhang, X.G.; Sun, L.; Li, C.X. Phenylboronate-diol crosslinked glycopolymeric nanocarriers for insulin delivery at physiological ph. Soft Matter 2014, 10, 911-920.
200. Li, W.J.; Liu, M.N.; Chen, H.B.; Xu, J.; Gao, Y.; Li, H.M. Phenylboronate-diol crosslinked polymer/SWCNT hybrid gels with reversible sol-gel transition. Polym. Adv. Technol. 2014, 25, 233-239.
201. Cook, M.T.; Smith, S.L.; Khutoryanskiy, V.V. Novel glycopolymer hydrogels as mucosa-mimetic materials to reduce animal testing. Chem. Commun. 2015, 51, 14447-14450.
202. Rabuka, D.; Parthasarathy, R.; Lee, G.S.; Chen, X.; Groves, J.T.; Bertozzi, C.R. Hierarchical assembly of model cell surfaces: Synthesis of mucin mimetic polymers and their display on supported bilayers. J. Am. Chem. Soc. 2007, 129, 5462-5471.
203. Rabuka, D.; Forstner, M.B.; Groves, J.T.; Bertozzi, C.R. Noncovalent cell surface engineering: Incorporation of bioactive synthetic glycopolymers into cellular membranes. J. Am. Chem. Soc. 2008, 130, 5947-5953.
204. Godula, K.; Rabuka, D.; Nam, K.T.; Bertozzi, C.R. Synthesis and microcontact printing of dual end-functionalized mucin-like glycopolymers for microarray applications. Angew. Chem. Int. Ed. Engl. 2009, 48, 4973-4976.
205. Godula, K.; Bertozzi, C.R. Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins. J. Am. Chem. Soc. 2012, 134, 15732-15742.
206. Authimoolam, S.P.; Puleo, D.A.; Dziubla, T.D. Affinity based multilayered polymeric self-assemblies for oral wound applications. Adv. Healthc. Mater. 2013, 2, 983-992.
207. Hamed, R.; Fiegel, J. Synthetic tracheal mucus with native rheological and surface tension properties. J. Biomed. Mater. Res. A 2014, 102, 1788-1798.
208. Groo, A.C.; Mircheva, K.; Bejaud, J.; Ailhas, C.; Panaiotov, I.; Saulnier, P.; Ivanova, T.; Lagarce, F. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules. Pharm. Res. 2014, 31, 1753-1765.
209. Burruano, B.T.; Schnaare, R.L.; Malamud, D. Synthetic cervical mucus formulation. Contraception 2002, 66, 137-140.
210. Burruano, B.T.; Schnaare, R.L.;Malamud, D. In vitro test to evaluate the interaction between synthetic cervical mucus and vaginal formulations. AAPS PharmSciTech 2004, 5, E17.
211. Wang, W.; Chance, D.L.; Mossine, V.V.; Mawhinney, T.P. Raft-based tri-component fluorescent glycopolymers: Synthesis, characterization and application in lectin-mediated bacterial binding study. Glycoconj. J. 2014, 31, 133-143.
212. Pieters, R.J. Intervention with bacterial adhesion by multivalent carbohydrates. Med. Res. Rev. 2007, 27, 796-816.
213. Imberty, A.; Chabre, Y.M.; Roy, R. Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins. Chem. Eur. J. 2008, 14, 7490-7499.
214. Shogren, R.; Gerken, T.A.; Jentoft, N. Role of glycosylation on the conformation and chain dimensions of o-linked glycoproteins: Light-scattering studies of ovine submaxillary mucin. Biochemistry 1989, 28, 5525-5536.
215. Levine, M.J.; Herzberg, M.C.; Levine, M.S.; Ellison, S.A.; Stinson, M.W.; Li, H.C.; Vandyke, T. Specificity of salivary-bacterial interactions-Role of terminal sialic-acid residues in interaction of salivary glycoproteins with streptococcus-sanguis and streptococcus-mutans. Infect. Immun. 1978, 19, 107-115.
216. Stinson, M.W.; Levine, M.J.; Cavese, J.M.; Prakobphol, A.; Murray, P.A.; Tabak, L.A.; Reddy, M.S. Adherence of streptococcus-sanguis to salivary mucin bound to glass. J. Dent. Res. 1982, 61, 1390-1393.
217. Hall, D.J.; Khutoryanskaya, O.V.; Khutoryanskiy, V.V. Developing synthetic mucosa-mimetic hydrogels to replace animal experimentation in characterisation of mucoadhesive drug delivery systems. Soft Matter 2011, 7, 9620-9623.
218. Lee, C.T.; Huang, C.P.; Lee, Y.D. Biomimetic porous scaffolds made from poly(L-lactide)-g-chondroitin sulfate blend with poly(L-lactide) for cartilage tissue engineering. Biomacromolecules 2006, 7, 2200-2209.